Truist Securities Maintains Buy on Privia Health Gr, Lowers Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
Truist Securities maintains a Buy rating on Privia Health Group (NASDAQ:PRVA) but lowers the price target from $28 to $24.
May 15, 2024 | 1:55 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Truist Securities maintains a Buy rating on Privia Health Group but lowers the price target from $28 to $24.
The maintained Buy rating suggests continued confidence in the company's long-term prospects, but the lowered price target indicates some short-term concerns or adjustments in valuation. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100